GB Patent

GB201710822D0 — Methods and medical uses relating to the treatment of hypoglycaemia

Assigned to REGION HOVEDSTADEN · Expires 2017-08-16 · 9y expired

What this patent protects

Patent listed against dasiglucagon-hydrochloride.

Drugs covered by this patent

dasiglucagon-hydrochloride (DASIGLUCAGON HYDROCHLORIDE)

Patent Metadata

Patent number: GB201710822D0
Jurisdiction: GB
Classification: —
Expires: 2017-08-16
Drug substance claim: No
Drug product claim: No
Assignee: REGION HOVEDSTADEN
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.